Bromocriptine Treatment is a pharmacological intervention that belongs to the class of dopamine agonist therapies and is specifically characterized by the use of bromocriptine to suppress pathological hyperprolactinemia by inhibiting prolactin secretion from pituitary lactotrophs.
1.6K
Publications
71.2K
Citations
5.3K
Authors
1.3K
Institutions
Publications per year
2017–2026
53
Parents
Publications
1.6K
Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum Cardiomyopathy
Karen Sliwa, Lori A. Blauwet, Kemi Tibazarwa et al. · Circulation · 2010 · 491 citations · Full text
Prolactin-Secreting Tumors and Hypogonadism in 22 Men
John N. Carter, John E. Tyson, George Tous et al. · New England Journal of Medicine · 1978 · 490 citations
Medicine, Endocrinology, Oncology +17
1–5 of 1.6K
Authors
5.3K
- AH
21
h-index
- SW
16
h-index
- MO
16
h-index
- AL
15
h-index
- LW
12
h-index
1–5 of 5.3K
Institutions
1.3K
Inserm
Paris, France
18 h-index
89 publications
8.3K citations
St Bartholomew's Hospital
London, United Kingdom
17 h-index
78 publications
5.7K citations
University of Milan
Milan, Italy
16 h-index
113 publications
5K citations
University College London
London, United Kingdom
15 h-index
47 publications
4.5K citations
University of Virginia
Charlottesville, United States
15 h-index
53 publications
5.8K citations
Harvard University
Cambridge, United States
15 h-index
25 publications
1.9K citations
National Institute of Neurological Disorders and Stroke
Bethesda, United States
15 h-index
66 publications
5.2K citations
National Institutes of Health
Bethesda, United States
15 h-index
53 publications
2.5K citations
1–8 of 1.3K
Venues
- The Journal of Clinical Endocrinology & Metabolism
JCEM · 126 publications · 9.7K citations
55
h-index
- Clinical Endocrinology
86 publications · 3.5K citations
35
h-index
- PubMed
Repository · 142 publications · 3.8K citations
33
h-index
- Endocrinology
59 publications · 2.6K citations
31
h-index
- Neurology
40 publications · 2.7K citations
30
h-index
1–5